I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusio..:
Lan, Shaowei
;
Li, Hui
;
Liu, Ying
...
OncoTargets and Therapy. 13 (2020) - p. 11499-11504 , 2020
Link:
https://doi.org/10.2147/ott.s278907
RT Journal T1
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.2147_ott.s278907&Exemplar=1&LAN=DE A1 Lan, Shaowei A1 Li, Hui A1 Liu, Ying A1 Xu, Jinhua A1 Huang, Zhicheng A1 Yan, Shi A1 Zhang, Qiang A1 Cheng, Ying PB Informa UK Limited YR 2020 SN 1178-6930 JF OncoTargets and Therapy VO 13 SP 11499 OP 11504 LK http://dx.doi.org/https://doi.org/10.2147/ott.s278907 DO https://doi.org/10.2147/ott.s278907 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)